Oncofertility Policy Initiatives: Affording Fertility Preservation

Approximately 10% of cancer patients are in their reproductive years. The chemotherapy, radiation, and surgery that now result in survival rates that are upwards of 80% can have devastating late and long-term effects, including fertility loss. While multiple fertility preservation techniques are available, many insurance providers do not cover these costs. The Oncofertility Consortium® works with scientists and policy makers at the state and federal level to ensure that patients will be able to afford fertility preservation prior to cancer treatment and prevent compounded costs for survivors when trying to build a family in the years after beating their initial cancer diagnosis. In recent years, the Consortium has worked on the following issues:

California State Assembly Bill AB 912: Health Care Coverage - Fertility Preservation

California State Assembly Bill AB 912 would mandate that insurance companies cover the cost of fertility preservation for patients undergoing treatment for cancer or other diseases that may cause fertility loss. A cost analysis of the bill determined that the mandate would increase insurance premiums at most by $0.03 per month. The Oncofertility Consortium® has submitted letters of support to the sponsor of the bill, Sharon Quirk-Silva, and released floor alerts prior to key votes. Read our letter of support for AB 912.

American Medical Association Resolution 114: Oncofertility and Fertility Preservation Treatment

Resolution 114 was introduced by the Michigan delegation of the American Medical Association (AMA), which calls for association wide support of insurance coverage of fertility preservation for cancer patients and supports lobbying for appropriate federal legislation requiring payment for oncofertility. The Oncofertility Consortium® provided financial, legal, and clinical information to the Michigan delegation to support this measure. In addition, Jacqueline Jeruss, MD, PhD, the Co-Director of the National Physicians Cooperative, presented her expert testimony to the AMA on the resolution, which was adopted in June 2013. The president-elect of the AMA, Robert Wah, MD, attended the 2013 Oncofertility Conference and gave remarks on the next steps of AMA involvement of oncofertility policy.

The Family Act of 2013

The Family Act has been introduced in the United States Senate and House of Representatives (S 881/HR 1851) to help many American couples afford the medical care necessary for them to have a child. In addition, The Family Act will provide critical financial support for young people with cancer, autoimmune disorders, and other conditions whose treatment may save their lives yet damage their ability to have children in the future. The Family Act would create a tax credit for eligible taxpayers to cover 50 percent of the cost of IVF and fertility preservation up to the maximum amount of the credit set by the existing Adoption Tax Credit ($12,970 this tax year). The Oncofertility Consortium® has written letters of support for the Family Act to congress and signed on to letters from aligned organizations.

 

To hear more about oncofertility and fertility preservation policy initiatives, sign up to the Oncofertility Consortium® Newsletter.